O4 Hubs detail
O4 Detail Hero Banner

ICPE Annual Conference

August 23–27, 2023

Halifax, Nova Scotia | Halifax Convention Centre

O4 1 Column (Full)
O4 Text Component

Improve your understanding of the safety and effectiveness of drugs and biologics in the real world

We’re excited to connect and collaborate with you during the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE). With decades of pharmacoepidemiology experience, our research team brings scientific rigor to protocol development, study design, project execution and reporting. Learn more about our work by attending one of our multiple presentations or meet with us at Booth 604-605.

O4 Topper
O4 2 Columns (1/2 - 1/2)
Dr. John Seeger

John D. Seeger, PharmD, DrPH

Chief Scientific Officer

In addition to his role with Optum, Dr. Seeger is adjunct faculty at the Harvard T.H. Chan School of Public Health. He has authored or co-authored over 100 articles and is a Fellow of the International Society for Pharmacoepidemiology.

Dr. Florence T. Wang

Florence T. Wang, ScD

Vice President, Epidemiology

Dr. Wang’s work is in the areas of vaccines, maternal and infant outcomes, neurology, oncology and cardiovascular disease.

O4 2 Columns (1/2 - 1/2)
Dr. Andrea K. Chomistek

Andrea K. Chomistek, MPH, ScD

Senior Scientist

Dr. Chomistek leads studies in the areas of endometriosis, osteoporosis, pregnancy, migraine and circulation.

Dr. Jessica M. Franklin

Jessica M. Franklin, PhD

Principal Consultant, RWE

Dr. Franklin has extensive experience designing and leading studies of the effectiveness, safety and utilization of medications from large health care databases, including claims and electronic health records.

O4 3 Columns (1/4 - 1/2 - 1/4)
O4 Text Component
O4 1 Column (Full)
O4 Tabs

See our experts’ research contributions

O4 50-50 Content Block

Pre-conference Skills Course | 2:00–6:00 p.m.

Propensity Scores in Pharmacoepidemiology

John D. Seeger, PharmD, DrPH – Optum

Jeremy A. Rassen, ScD – Aetion

Issues of bias and confounding relate to study design and analysis in the setting of non-random ‎treatment assignment where compared subjects might differ substantially with respect to comorbidities. ‎Failing to address a lack of balance in the covariates between treated and comparison groups can ‎produce confounded estimates of treatment effect. This course aims to describe the use of propensity ‎scores to address confounding in pharmacoepidemiology.‎

O4 50-50 Content Block

Symposia & Workshops: Session 2 | 10:30 a.m.–12:00 p.m.

Curriculum in Pharmacoepidemiology Training and Alignment with Updated Core Competencies: State of the Field and Educational Needs Assessment

Oral Presentations: Session 2 - Vaccine Potpourri | 5:15–5:30 p.m.

The Contribution of Immunization Information System Data to Claims-Based Capture of Vaccines Used to Prevent Mpox and Implications for Claims-Based Mpox Surveillance

Poster Session A | 8:00 a.m.–6:00 p.m.

Characterization of U.S. Adults Aged 18–64 Years Vaccinated Against Mpox within the Food and Drug Administration Biologics Effectiveness and Safety (BEST) Initiative

Development and Validation of a Claims-based Algorithm for Moderate-to-Severe Atopic Dermatitis

Development and Validation of Claims-based Algorithms for Conjunctivitis and Keratitis

Medical chart review of selected adverse event of special interest (AESI) to support rapid safety assessment of JCOVDEN vaccine: a validation study using US electronic health records and claims data

Monitoring Results From a Postapproval Safety Study of Pfizer-BioNTech COVID-19 Vaccine in the United States: Vaccine Utilization and Incidence Rates of Myocarditis/Pericarditis

Pregnancy during a pandemic: pregnancy occurrence and outcomes during the SARS-CoV-2 pandemic

Use of Janssen Ad26.COV2.S COVID-19 Vaccine (JCOVDEN) and mRNA COVID-19 Vaccines in Four Large US National Insurers

Use of US Health Insurance Claims Data to Determine Cause of Death

Validation of a Claims-based Algorithm for Myocarditis/Pericarditis using Medical Chart Review

O4 50-50 Content Block

Oral Presentations: Session 4 - Vaccines: Boosting Confidence | 1:00–1:15 p.m.

Effectiveness of BNT162b2 COVID-19 Vaccine in US Children Aged 5-17 Years

Oral Presentations: Session 4 - Lightning Session 2 | 2:10–2:15 p.m.

The Contribution of Immunization Information System Data to Claims-Based Vaccine Administration Capture Over Time and Implications for Claims-Based COVID-19 Vaccine Studies

Symposia & Workshops: Session 3 | 4:15–5:45 p.m.

Building Consensus on RWE Evaluation: Standardized Tool for Assessing Validity in RWE studies of Medication Safety and Effectiveness

Poster Session B | 8:00 a.m.–6:00 p.m.

Use of Very Low-Dose Vaginal Estrogens Among Postmenopausal Women in the US

O4 50-50 Content Block

Oral Presentations: Session 6 - Vaccines: Timing is Everything | 1:30–1:45 p.m.

Are Major Congenital Malformations (MCMs) Identifiable Among Claims for Non-Live Births?

Oral Presentations: Session 6 - Lightning Session 2 | 2:10–2:15 p.m.

Safety Monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 Vaccines in U.S. Children aged 5-17 years

Poster Session C | 8:00 a.m.–1:30 p.m.

Effectiveness of Monovalent COVID-19 Booster/Additional Vaccine Doses in the United States

Factors Associated with Health Plan Disenrollment During Pregnancy Among US Commercially Insured Women

Validation of a Claims-based Algorithm for Myocarditis/Pericarditis in Pediatric Patients

O4 Simple Cards

Capabilities to answer a variety of research questions

O4 Simple Card

Optum Epidemiology overview

Advance public health and safety with our trusted epidemiologists

O4 Simple Card

Understanding maternal health outcomes

The Optum® Dynamic Assessment of Pregnancies and Infants links women and their infants’ data to answer questions about maternal health.

O4 Simple Card

Leveraging external control arms

Optum Epidemiology can develop and execute external control arm studies, an emerging real-world evidence (RWE) option.

Connect with our team so we can help you put evidence into action

O4 50-50 Content Block

Optum Epidemiology publications

Discover recent publications by Optum Epidemiology experts.